Augusta University
Clinical trials sponsored by Augusta University, explained in plain language.
-
New combo therapy targets myeloma and kidney failure in early trial
Disease control Recruiting nowThis study tests a combination of four drugs (daratumumab, bortezomib, cyclophosphamide, and dexamethasone) in 30 people newly diagnosed with multiple myeloma who also have kidney failure. The goal is to see how well the treatment shrinks the cancer and improves kidney function a…
Phase: EARLY_PHASE1 • Sponsor: Augusta University • Aim: Disease control
Last updated May 26, 2026 07:27 UTC
-
New CML drug combo aims for deeper remission without lifelong side effects
Disease control Recruiting nowThis study tests a new drug called asciminib as the first treatment for adults newly diagnosed with chronic myeloid leukemia (CML). If the drug doesn't work well enough after up to 3 years, patients can also get a low dose of another standard drug. The goal is to see if this appr…
Phase: PHASE2 • Sponsor: Augusta University • Aim: Disease control
Last updated May 26, 2026 07:24 UTC
-
Could brain zaps reverse Alzheimer's? new trial begins
Disease control Recruiting nowThis early-stage study tests a procedure called deep brain stimulation (DBS) for people with early Alzheimer's disease. It involves implanting a device that sends mild electrical pulses to a brain area involved in memory. The goal is to see if DBS can keep thinking and memory sta…
Phase: PHASE1 • Sponsor: Augusta University • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Vibrating machine may soothe arthritic knees without drugs
Symptom relief Recruiting nowThis study tests whether using a whole-body vibration machine at home for 12 weeks can reduce knee pain and inflammation in people with osteoarthritis. Researchers will measure pain sensitivity, blood vessel function, and inflammation levels in 30 adults aged 40-75. The goal is t…
Phase: NA • Sponsor: Augusta University • Aim: Symptom relief
Last updated May 26, 2026 07:22 UTC